UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MtDNA As a Cancer Marker: A Finally Closed Chapter?

Current genomics, 2017-06, Vol.18 (3), p.255-267

Kirches, Elmar

2017

Volltextzugriff (PDF)

mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models

Clinical cancer research, 2013-03, Vol.19 (5), p.1180-1189

2013

Volltextzugriff (PDF)

Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas

Acta neuropathologica, 2021-11, Vol.142 (5), p.873-886

2021

Volltextzugriff (PDF)

Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells

European journal of cancer (1990), 2017-03, Vol.73, p.9-21

2017

Volltextzugriff (PDF)

Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells

European journal of cancer (1990), 2012-08, Vol.48 (12), p.1831-1841

2012

Volltextzugriff (PDF)

The Integrin Inhibitor Cilengitide Affects Meningioma Cell Motility and Invasion

Clinical cancer research, 2013-10, Vol.19 (19), p.5402-5412

2013

Volltextzugriff (PDF)

Impact of an additional chronic BDNF reduction on learning performance in an Alzheimer mouse model

Frontiers in behavioral neuroscience, 2015-03, Vol.9, p.58-58

2015

Volltextzugriff (PDF)

Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas

Clinical cancer research, 2005-06, Vol.11 (11), p.4074-4082

2005

Volltextzugriff (PDF)

PATH-38. MOLECULAR CHARACTERIZATION OF GLIOMA TISSUE AFTER TTFIELDS TREATMENT

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v176-v177

2023

Volltextzugriff (PDF)

High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples

International journal of cancer, 2001-08, Vol.93 (4), p.534-538

2001

Volltextzugriff (PDF)

KLF4K409Q–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment

Acta neuropathologica communications, 2020-04, Vol.8 (1), p.1, Article 41

2020

Volltextzugriff (PDF)

Minocycline, a possible neuroprotective agent in Leber’s hereditary optic neuropathy (LHON): Studies of cybrid cells bearing 11778 mutation

Neurobiology of disease, 2007-12, Vol.28 (3), p.237-250

2007

Volltextzugriff (PDF)

Crispr/Cas-based modeling of NF2 loss in meningioma cells

Journal of neuroscience methods, 2021-05, Vol.356, p.109141-109141, Article 109141

2021

Volltextzugriff (PDF)

Mitoferrin-1 is required for brain energy metabolism and hippocampus-dependent memory

Neuroscience letters, 2019-11, Vol.713, p.134521-134521, Article 134521

2019

Volltextzugriff (PDF)

EXTH-64. SMALL GTPASES IN MENINGIOMAS: PROLIFERATION, MIGRATION, SURVIVAL, POTENTIAL TREATMENT AND INTERACTIONS

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii101-ii101

2020

Volltextzugriff (PDF)

Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development

Journal of the neurological sciences, 2020-01, Vol.408, p.116553-116553, Article 116553

2020

Volltextzugriff (PDF)

AKT1 E17K -mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363

Neuropathology and applied neurobiology, 2022-02, Vol.48 (2), p.e12780

2022

Volltextzugriff (PDF)

Clinical Characteristics and Magnetic Resonance Imaging–Based Prediction of the KLF4 Mutation in Meningioma

World neurosurgery, 2021-10, Vol.154, p.e665-e670

2021

Volltextzugriff (PDF)

Clinical Characteristics and Magnetic Resonance Imaging–Based Prediction of the KLF4K409Q Mutation in Meningioma

World neurosurgery, 2021-10, Vol.154, p.e665-e670

2021

Volltextzugriff (PDF)

A new amplicon‐based gene panel for next generation sequencing characterization of meningiomas

Brain pathology (Zurich, Switzerland), 2022-03, Vol.32 (2), p.e13046-n/a

2022

Volltextzugriff (PDF)

Integrin inhibition as a potential target for invasive meningiomas

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e22140-e22140

2013

Volltextzugriff (PDF)

Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas

Journal of the neurological sciences, 2017-09, Vol.380, p.112-121

2017

Volltextzugriff (PDF)

AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363

Neuropathology and applied neurobiology, 2022-02, Vol.48 (2), p.e12780-n/a

2022

Volltextzugriff (PDF)

Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence

Neuro-oncology (Charlottesville, Va.), 2017-08, Vol.19 (8), p.1088-1096

2017

Volltextzugriff (PDF)

Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.1193-1201

2011

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(88)
Buchkapitel
(2)

Sprache

Englisch
(88)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MtDNA As a Cancer Marker: A Finally Closed Chapter?

mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models

Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas

Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells

Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells

The Integrin Inhibitor Cilengitide Affects Meningioma Cell Motility and Invasion

Impact of an additional chronic BDNF reduction on learning performance in an Alzheimer mouse model

Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas

PATH-38. MOLECULAR CHARACTERIZATION OF GLIOMA TISSUE AFTER TTFIELDS TREATMENT

High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples

KLF4K409Q–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment

Minocycline, a possible neuroprotective agent in Leber’s hereditary optic neuropathy (LHON): Studies of cybrid cells bearing 11778 mutation

Crispr/Cas-based modeling of NF2 loss in meningioma cells

Mitoferrin-1 is required for brain energy metabolism and hippocampus-dependent memory

EXTH-64. SMALL GTPASES IN MENINGIOMAS: PROLIFERATION, MIGRATION, SURVIVAL, POTENTIAL TREATMENT AND INTERACTIONS

Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development

AKT1 E17K -mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363

Clinical Characteristics and Magnetic Resonance Imaging–Based Prediction of the KLF4 Mutation in Meningioma

Clinical Characteristics and Magnetic Resonance Imaging–Based Prediction of the KLF4K409Q Mutation in Meningioma

A new amplicon‐based gene panel for next generation sequencing characterization of meningiomas

Integrin inhibition as a potential target for invasive meningiomas

Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas

AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363

Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence

Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells

Suchergebnisse filtern